Article ; Online: A sting in the tail-are antibodies against the C-terminus of Plasmodium falciparum circumsporozoite protein protective?
2023 Volume 15, Issue 6, Page(s) e17556
Abstract: Malaria remains a huge burden on global public health. Annually there are more than 200 million cases with > 600,000 deaths worldwide, the vast majority of which occur within Sub-Saharan Africa (WHO; World Malaria Report, 2021). Malaria disease is the ... ...
Abstract | Malaria remains a huge burden on global public health. Annually there are more than 200 million cases with > 600,000 deaths worldwide, the vast majority of which occur within Sub-Saharan Africa (WHO; World Malaria Report, 2021). Malaria disease is the consequence of infection by a protozoan parasite from the genus Plasmodium with most morbidity and mortality caused by P. falciparum. With rates of infection plateauing and rebounding in some areas (in particular, as a result of the disruption caused by the COVID-19 pandemic), there have been increasing calls for new initiatives that can reduce malaria incidence towards local elimination or the hoped for goal of global eradication. In 2021, the World Health Organisation approved the first malaria vaccine RTS,S/AS01 (also called Mosquirix™), indicating it to be safe for use in young children and advocating its integration into routine immunisation programmes. Approval of this vaccine clearly represents a major landmark in global efforts towards malaria control and eradication aspirations. RTS,S modest efficacy, however, points at the need to better understand immune responses to the parasite if we hope to design next generation malaria vaccines with increased potency. |
---|---|
MeSH term(s) | Child ; Humans ; Child, Preschool ; Plasmodium falciparum ; Pandemics ; COVID-19/epidemiology ; Malaria, Falciparum/prevention & control ; Antibodies ; Malaria/epidemiology ; Malaria Vaccines ; Protozoan Proteins/genetics |
Chemical Substances | Antibodies ; Malaria Vaccines ; Protozoan Proteins |
Language | English |
Publishing date | 2023-04-21 |
Publishing country | England |
Document type | Journal Article ; Comment |
ZDB-ID | 2467145-9 |
ISSN | 1757-4684 ; 1757-4676 |
ISSN (online) | 1757-4684 |
ISSN | 1757-4676 |
DOI | 10.15252/emmm.202317556 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6784: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.